Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Medlab Clinical ( (AU:MDC) ) has provided an update.
Medlab Clinical Limited has released its quarterly cash flow report for Q2 2025, indicating a challenging financial position with no cash receipts and a closing balance of $5,000. The company continues discussions related to business acquisition and plans to hold AGMs in February 2025, with its ASX removal scheduled for the end of the month. These developments may impact Medlab’s positioning in the market and its future operations.
More about Medlab Clinical
Medlab Clinical Limited operates in the healthcare industry, focusing on innovative research and development. The company is known for its work in pharmaceutical and nutraceutical products, aiming to improve patient care and health outcomes.
Average Trading Volume: 10,000
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $9.9M
For detailed information about MDC stock, go to TipRanks’ Stock Analysis page.